In the present study, we consecutively collected data from 294 mCRC cases that underwent routine mutational profiling at our institution between January 2016 and January 2020 using the Oncomine Solid Tumor panel, which comprises the most frequently mutated and actionable genes in CRC except for APC. The gene discussed is APC; the disease is colorectal carcinoma.